Cronos Group Inc. (CRON) Stock
Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks
Cronos Group Inc. (CRON) closed at USD 3.16 on 2026-10-14, a change of +26.9 % over the past year, with a market capitalization of USD 1.18B.
Cronos Group Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 3.16 |
| 2026-10-13 | 3.20 |
| 2026-10-12 | 3.21 |
| 2026-10-09 | 3.23 |
| 2026-10-08 | 3.22 |
| 2026-10-07 | 3.24 |
| 2026-10-06 | 3.29 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Cronos Group Inc. key figures
- Previous close
- USD 3.16 (2026-10-14)
- 1-year change
- +26.9 %
- Market cap
- USD 1.18B
- Enterprise value
- USD 431.97M
- P/E ratio (trailing)
- 16.84
- P/E ratio (forward)
- -80.00
- EPS (trailing)
- 0.19
- EPS (forward)
- -0.04
- PEG ratio
- n/a
- Price to book
- 1.11
- Revenue growth
- 58.4 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 3.90
- Employees
- 610
- Analyst consensus (third-party)
- strong_buy
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Cronos Group Inc.
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Cronos Group Inc. and compare it with other stocks.
Analyze CRONAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Cronos Group Inc. shares.